Changes are happening - please bear with us while we update our site.

Changes are happening - please bear with us while we update our site. Click here to give us your advice and feedback.

Here’s why the Brainchip (ASX:BRN) share price is so volatile today

It's been a roller-coaster day for the Brainchip Holdings Ltd (ASX: BRN) share price after the company posted its Q2 trading result. 

It’s been a roller-coaster day for the Brainchip Holdings Ltd (ASX: BRN) share price after the company posted its second-quarter trading result.

The Brainchip share price initially raced out of the gates up 15%. However, it has abandoned all of those gains and is now up 0.35%.

Today’s share price movement is somewhat illustrative of the past month for Brainchip shareholders.

Despite rising 114% in 2022, here’s why I’m avoiding Brainchip (ASX: BRN)

Brainchip’s share price started the year just below $0.37 before rocketing to a high of $2.34.

But it’s now retracted half of the share price rise to currently rest at $1.44.

BRN share price

Source: Rask Media BRN 1-month share price
Source: Rask Media BRN 1-month share price

Q2 update

Key highlights from the second quarter ending December 31 include:

  • Cash receipts if US$1.1 million
  • Net cash outflow of US$3.4 million
  • Cash balance of US$19.4 million
  • Appointment of new CEO Sean Hehir
  • Addition of Non-Executive Director Pia Turcinov

Brainchip continues to be loss-making, recording just over $1 million in sales for the quarter.

Throughout the quarter, Brainchip began disseminating testing kits for its Akida AKD100 neuromorphic processors chips to potential partners.

“In the coming quarter, the Company will be focused on the Akida go-to-market strategy refinement and adding additional resources to our Sales and Marketing teams”

The company reiterated the US Patents and Trademarks Office had approved three key patents relating to Brainchips Akida technology.

It also repeated the previously announced MegaChips license agreement. Note that it will only contribute $2 million of revenue initially.

To America and beyond

Brainchip announced that it will be setting American Depository Receipts (ADRs).

Effectively, it allows North American investors to trade Brainchips shares on local exchanges, rather than needing to buy and sell on the ASX.

For current or future ASX investors, it does not impact your shareholding.

Raising on the cards in 2022?

Today’s release didn’t provide much colour on Brainchips operations that wasn’t already known by the market.

At the current burn rate, the company has about five quarters, or just over a year, of cash on hand to support its growth.

Subsequently, the business may look to raise capital for shareholders at some point in 2022.

This is especially true given the rapid share price appreciation. Although management has made no indication of a raising thus far.

Personally, I’m not that excited about the Brainchip share price.

Instead, check out four ASX shares I’m watching in 2022

$50,000 per year in passive income from shares? Yes, please!

With interest rates UP, now could be one of the best times to start earning passive income from a portfolio. Imagine earning 4%, 5% — or more — in dividend passive income from the best shares, LICs, or ETFs… it’s like magic.

So how do the best investors do it?

Chief Investment Officer Owen Rask has just released his brand new passive income report. Owen has outlined 10 of his favourite ETFs and shares to watch, his rules for passive income investing, why he would buy ETFs before LICs and more.

You can INSTANTLY access Owen’s report for FREE by CLICKING HERE NOW and creating a 100% FREE Rask Account.

(Psst. By creating a free Rask account, you’ll also get access to 15+ online courses, 1,000+ podcasts, invites to events, a weekly value investing newsletter and more!)

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.

At the time of publishing, Lachlan does not have a financial or commercial interest in any of the companies or funds mentioned.
Skip to content